(Reuters) -Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage ...

RNA drugs might be able to protect against a huge range of viruses by turning on key parts of our innate defences against ...

The top public health officials during President Donald Trump's first term praised mRNA vaccines. In the second term, ...

The list seems to have been used as research for the 2024 book, "Toxic Shot: Facing the Dangers of the COVID 'Vaccines.'" The ...

Director Jay Bhattacharya claims the federal government recently canceled millions of dollars’ worth of mRNA research ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

( NewsNation) — National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but ...

Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research ...

The Trump administration’s COVID-revenge campaign has laid the groundwork for Kennedy’s larger agenda.

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story NIH director: Lack of public trust led ...

The NIH’s Jay Bhattacharya tried his best pitch to explain the Trump administration’s shift away from mRNA vaccine research.

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.